One may think of a baby representing new life and possibilities. These five baby macaque monkeys, however, will almost certainly experience anxiety, depression, and schizophrenia in their lifetimes, as a result of gene modification—another one of China’s scientific experiments that raises ethical questions on cloning.
Circadian disruption means that a normal sleep cycle is difficult for an individual to experience. Most creatures follow a circadian rhythm, a cycle of waking and sleeping during certain points of the day and night. A disruption to that rhythm will not only cause abnormal sleep, but other adverse side effects.
Circadian disruptions can come from external factors, like a person working a night shift but also staying awake to be with family.
The scientists used a genetic editing tool to “knock out” a specific gene from healthy embryos. When a gene is knocked out, it means that it no longer functions. For these monkeys, the BMAL-1 gene was the target of the knockout.
Unethical Development
China allows research that is ethically banned in most countries. Cloning and gene modification has already stirred controversy. John Bergeron, a professor of medicine at McGill University, likened gene-editing to opening Pandora’s Box, due to potential commercial uses of gene modification.Though He was fired and condemned by Chinese authorities, his application for the project carried official stamps and signatures from members of an ethical committee. Along with massive amounts of funding required for such work, which comes from an unknown benefactor, he was said to be on unpaid leave since February 2018.
China has allowed other forms of experiments banned in other countries. In November 2017, an Italian doctor announced that he would perform the first human head transplant in China with the support of the Chinese regime and a team of Chinese surgeons. Dr. Sergio Canavero claimed that his team had already successfully completed the procedure on cadavers. The controversial procedure, which was condemned by the United States and the European Union, raised biomedical ethical concerns over China’s lack of oversight.